Dr. Tzachanis on the Likelihood of Cure With CAR T-Cell Therapy in Lymphoma
Dimitrios Tzachanis, MD, PhD, discusses the likelihood of cure with CAR-T cell therapy in lymphoma.
Dimitrios Tzachanis, MD, PhD, hematologist/medical oncologist and assistant professor of medicine, University of California, San Diego Health, discusses the likelihood of cure with CAR-T cell therapy in lymphoma.
According to Tzachanis, it is difficult to definitively say that a patient is cured from their cancer.
However, since diffuse large B-cell lymphoma and acute lymphoblastic leukemia are fast-growing diseases, patients who derive at least 2-year remissions with CAR T-cell therapy may be effectively cured, concludes Tzachanis.
World Pancreatic Cancer Day 2024: Looking Back at Progress in Cell and Gene Therapy
November 21st 2024In observance of World Pancreatic Cancer Day, held on the third Thursday of November each year, we took a look back at the past year's news in cell and gene therapy for pancreatic cancer indications.
